Q-ventures Program Ii (co-invest Holdings) Ltd. - Net Worth and Insider Trading

Q-ventures Program Ii (co-invest Holdings) Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Q-ventures Program Ii (co-invest Holdings) Ltd. owns 1 companies in total, including Vir Biotechnology Inc (VIR) .

Click here to see the complete history of Q-ventures Program Ii (co-invest Holdings) Ltd.’s form 4 insider trades.

Insider Ownership Summary of Q-ventures Program Ii (co-invest Holdings) Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
VIR	Vir Biotechnology Inc	2019-10-10	10 percent owner

Q-ventures Program Ii (co-invest Holdings) Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Q-ventures Program Ii (co-invest Holdings) Ltd. Ownership Network

Ownership Network List of Q-ventures Program Ii (co-invest Holdings) Ltd.

No Data

Ownership Network Relation of Q-ventures Program Ii (co-invest Holdings) Ltd.

Q-ventures Program Ii (co-invest Holdings) Ltd. Owned Company Details

What does Vir Biotechnology Inc do?

Who are the key executives at Vir Biotechnology Inc?

Q-ventures Program Ii (co-invest Holdings) Ltd. is the 10 percent owner of Vir Biotechnology Inc. Other key executives at Vir Biotechnology Inc include Chief Executive Officer Backer Marianne De , Chief Technology Officer Ann M. Hanly , and Chief Financial Officer Sung Lee .

Vir Biotechnology Inc (VIR) Insider Trades Summary

Over the past 18 months, Q-ventures Program Ii (co-invest Holdings) Ltd. made no insider transaction in Vir Biotechnology Inc (VIR). Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 952,542 shares made by Svf Endurance (cayman) Ltd , a net sale of 22,889 shares made by Phillip Pang , and a net sale of 55,500 shares made by George A Scangos .

In summary, during the past 3 months, insiders sold 20,337 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 20,337 shares. During the past 18 months, 1,173,278 shares of Vir Biotechnology Inc (VIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,173,278 shares.

Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vir Biotechnology Inc Insider Transactions

No Available Data

Q-ventures Program Ii (co-invest Holdings) Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Q-ventures Program Ii (co-invest Holdings) Ltd.. You might contact Q-ventures Program Ii (co-invest Holdings) Ltd. via mailing address: C/o Grove Street Advisors, Llc, 2221 Washington St., Bldg. 1, Suite 201, Newton Ma 02462.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.